Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (371-380 of 448) with videos related to

Pageof 45
Sort By:
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Arthritis and Rheumatism|May 30, 2009
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceEric Hachulla, Pascal de Groote, Virginie Gressin, et al.
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Arthritis and Rheumatism|April 11, 2012
Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunityEugénie Koumakis, Matthieu Giraud, Philippe Dieudé, et al.
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|February 3, 2011
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchChristian Beyer, Jörg H W Distler, Yannick Allanore, et al.
Pageof 45

Showing results (371-380 of 448) with videos related to

Sort By:
Pageof 45
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Arthritis and Rheumatism|May 30, 2009
The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in FranceEric Hachulla, Pascal de Groote, Virginie Gressin, et al.
Annals of the Rheumatic Diseases|August 19, 2019
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrualSerena Fasano, Antonella Riccardi, Valentina Messiniti, et al.
Journal of Scleroderma and Related Disorders|May 19, 2025
Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'Corrado Campochiaro, Yossra A Suliman, Dilia Giuggioli, et al.
Arthritis and Rheumatism|April 11, 2012
Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunityEugénie Koumakis, Matthieu Giraud, Philippe Dieudé, et al.
Rheumatology (Oxford, England)|June 3, 2025
Temporal trends in vascular medication use in 8079 patients with systemic sclerosis: insights to inform future trials and therapeutic strategies from the EUSTAR cohortStefano Di Donato, John D Pauling, Sheila Ramjug, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|February 3, 2011
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchChristian Beyer, Jörg H W Distler, Yannick Allanore, et al.
Pageof 45